GlassScriptPhysician profile
Kimberly Shawn Fields
NPI 1528238458
$2,598.85
in general payments reported to CMS, 2019-2025
16 companies · $228 in 2025
The $228 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $699 · 2022: $652 · 2023: $624 · 2024: $396 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,136 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,135.66 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $572.44 | 2021-2024 | Abilify Maintena, Rexulti, Abilify Asimtufii |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $571.30 | 2021-2025 | Caplyta |
| Neurocrine Biosciences, INC. | $405.58 | 2021-2023 | Ingrezza |
| Janssen Pharmaceuticals, INC | $253.19 | 2021-2023 | Spravato |
| Teva Pharmaceuticals USA, INC. | $197.85 | 2022-2025 | Uzedy, Austedo Xr, Austedo |
| Takeda Pharmaceuticals U.S.A., INC. | $103.38 | 2021-2022 | |
| Abbvie INC. | $82.81 | 2022-2023 | |
| Lundbeck LLC | $80.52 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $76.14 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $73.78 | 2021-2022 | |
| Corium, LLC | $53.90 | 2022-2023 | Azstarys |
| Alkermes, INC. | $36.88 | 2022-2023 | Aristada, Lybalvi |
| Avanir Pharmaceuticals, INC. | $27.52 | 2021 | |
| Indivior INC. | $25.98 | 2023 | Sublocade |
| Tris Pharma INC | $19.04 | 2023 | Dyanavel Xr |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $18.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.